Document Detail


Comparison of frame-based and frameless stereotactic hematoma puncture and subsequent fibrinolytic therapy for the treatment of supratentorial deep seated spontaneous intracerebral hemorrhage.
MedLine Citation:
PMID:  17674294     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: This study compared the technical implications and clinical outcome of patients treated for an intracerebral hemorrhage using two minimally invasive procedures: frame-based stereotactic hematoma aspiration and frameless navigation-guided hematoma aspiration followed by fibrinolysis. METHODS: Thirty patients with a spontaneous supratentorial intracerebral hemorrhage, which was treated by a frame-based (n=15) and frameless (n=15) hematoma aspiration followed by subsequent fibrinolysis with urokinase, were retrospectively reviewed. The data for the two subsets of patients were analyzed with regard to hematoma reduction, Glasgow Coma Scale (GCS), and degree of weakness. RESULTS: In the frame-based stereotactic hematoma aspiration group, the volume of the hematoma was 15.4-100.0 mL (mean: 40.7+/-24.4), the GCS upon admission was 4-15 (mean: 10.1+/-3.0), and the grade of weakness upon admission was 1-5 (mean: 2.1+/-0.9). On the other hand, in the frameless navigation-guided hematoma aspiration group, the hematoma volume was 15.2-62.0 mL (mean: 30.0+/-15.2), the GCS upon admission was 7-15 (mean: 13.0+/-2.4), and the grade of weakness upon admission was 1-4 (mean: 2.3+/-1.2). The drainage catheter was in place for a mean duration of 5.1+/-2.4 days (range: 1-12 days). In the frame-based group, the initial hematoma was reduced by -115-88.5% (mean: 52+/-31.5) immediately after surgery, and 90.5% (41-100%) of the initial volume 14 days after surgery. In the frameless group, the initial hematoma was reduced by 11.7-90.8% (mean 57.3+/-25.1) immediately after surgery and 95.8% (87.7-100%) 14 days after surgery. The GCS score and the degree of weakness were evaluated 14 days after surgery, and the Glasgow outcome scale (GOS) score was evaluated at discharge. There were no statistically significant differences between the two groups. CONCLUSION: The frame-based group and the frameless group followed by fibrinolysis had similar outcomes, and both procedures effectively reduced the intracerebral hemorrhage volume within a short period of time. In addition, these procedures are simple, precise, safe, and brief with a very low rebleeding rate and mortality.
Authors:
I-S Kim; B-C Son; S-W Lee; J-H Sung; J-T Hong
Related Documents :
9880384 - Postoperative outcome of 37 patients with lobar intracerebral hemorrhage related to cer...
16965864 - Intensity-modulated radiotherapy significantly reduces xerostomia compared with convent...
8177384 - Treatment of hypertensive cerebellar hemorrhage--surgical or conservative management?
7931614 - Clinical and radiological evaluation of long-term results of stereotactic proton beam r...
17899144 - The use of cyanoacrylates for wound closure in head and neck surgery.
15464314 - Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Minimally invasive neurosurgery : MIN     Volume:  50     ISSN:  0946-7211     ISO Abbreviation:  Minim Invasive Neurosurg     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-08-03     Completed Date:  2007-10-17     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9440973     Medline TA:  Minim Invasive Neurosurg     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  86-90     Citation Subset:  IM    
Affiliation:
Department of Neurosurgery, St. Vincent Hospital, The Catholic University of Korea, Suwon, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Cerebral Hemorrhage / drug therapy*,  pathology,  surgery*
Drainage / instrumentation,  methods
Female
Fibrinolytic Agents / therapeutic use*
Glasgow Coma Scale
Hematoma / drug therapy*,  pathology,  surgery*
Humans
Male
Middle Aged
Neuronavigation / methods*,  statistics & numerical data
Postoperative Hemorrhage / prevention & control
Recurrence
Retrospective Studies
Stereotaxic Techniques / statistics & numerical data*
Time Factors
Treatment Outcome
Urokinase-Type Plasminogen Activator / therapeutic use
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; EC 3.4.21.73/Urokinase-Type Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Recurrence after successful percutaneous endoscopic lumbar discectomy.
Next Document:  Percutaneous endoscopic discectomy for far lateral lumbar disc herniations: prospective study and ou...